GLA 抗体
Quick Overview for GLA 抗体 (ABIN7114449)
抗原
See all GLA 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Protein A+G purification
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- galactosidase, alpha
-
亚型
- IgG2a
-
-
anti-Galactosidase, alpha (GLA) (AA 81-429) antibody
GLA 适用: 人 WB, IHC, IP, FACS, ICC 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 81-429) antibodyGLA 适用: 人 WB, IHC 宿主: 小鼠 Monoclonal C8 unconjugated
anti-Galactosidase, alpha (GLA) antibodyKO Validated GLA 适用: 人 WB, IP, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-80) antibodyGLA 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 147-371) antibodyGLA 适用: 人 WB, IHC, IP, FACS, ICC 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-429) antibodyGLA 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 83-112), (N-Term) antibodyGLA 适用: 人 WB, FACS, IF, IHC (p) 宿主: 兔 Polyclonal RB19115 unconjugated
anti-Galactosidase, alpha (GLA) (AA 101-200) antibodyGLA 适用: 人, 小鼠, 大鼠 WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 32-429) antibodyGLA 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-429) antibodyGLA 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
-
-
应用备注
- WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
有效期
- 12 months
-
-
- GLA (Galactosidase, alpha (GLA))
-
别名
- Alpha galactosidase A
-
背景
- Synonyms:Alpha galactosidase A, galactosidase, alpha Background:GLA, also named as Melibiase, Agalsidase and Alpha-galactosidase A, belongs to the glycosyl hydrolase 27 family. It hydrolyzes terminal, non-reducing alpha-D-galactose residues in alpha-D-galactosides, including galactose oligosaccharides, galactomannans and galactolipids. Fabry disease is an X-linked lysosomal storage disorder resulting from the deficient activity of GLA. Enzyme replacement therapy(ERT) with GLA is currently the most effective therapeutic strategy for patients with Fabry disease, a lysosomal storage disease.
-
分子量
- 49 kDa
-
基因ID
- 2717
-
UniProt
- P06280
-
途径
- SARS-CoV-2 Protein Interactome
抗原
-
